NEPHROS, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
NEPHROS, INC. (NEPH) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $1.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-10
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $1.20M, a 405.06% increase year-over-year.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $140.00K, a 74.91% decline year-over-year.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $62.00K, a 82.23% decline year-over-year.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $337.00K, a 84.15% increase year-over-year.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $1.19M, a 1513.51% increase from fiscal 2024.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $74.00K.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$1.57M.
- NEPHROS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$4.28M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.20M 10-Q · filed 2026-08-10 | $1.34M 10-Q · filed 2026-08-10 | $1.40M derived: sum of 3 quarters · filed 2026-08-10 | $1.74M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $140.00K 10-Q · filed 2026-05-07 | $202.00K derived: sum of 2 quarters · filed 2026-05-07 | $539.00K derived: sum of 3 quarters · filed 2026-05-07 | $776.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $399.00K derived: sum of 2 quarters · filed 2026-03-12 | $636.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.19M 10-K · filed 2026-03-12 |
| 2025-09-30 | $337.00K 10-Q · filed 2025-11-06 | $574.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.13M 10-Q · filed 2025-11-06 | $1.48M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $237.00K 10-Q · filed 2026-08-10 | $795.00K 10-Q · filed 2026-08-10 | $1.14M derived: sum of 3 quarters · filed 2026-08-10 | $1.33M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $558.00K 10-Q · filed 2026-05-07 | $907.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.09M derived: sum of 3 quarters · filed 2026-05-07 | $801.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $532.00K derived: sum of 2 quarters · filed 2026-03-12 | $243.00K derived: sum of 3 quarters · filed 2026-03-12 | $74.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $183.00K 10-Q · filed 2025-11-06 | -$106.00K derived: sum of 2 quarters · filed 2025-11-06 | -$275.00K 10-Q · filed 2025-11-06 | -$929.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$289.00K 10-Q · filed 2025-08-07 | -$458.00K 10-Q · filed 2025-08-07 | -$1.11M derived: sum of 3 quarters · filed 2025-08-07 | -$1.29M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$169.00K 10-Q · filed 2025-05-15 | -$823.00K derived: sum of 2 quarters · filed 2025-05-15 | -$1.00M derived: sum of 3 quarters · filed 2025-05-15 | -$1.44M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$836.00K derived: sum of 2 quarters · filed 2025-03-24 | -$1.27M derived: sum of 3 quarters · filed 2025-03-24 | -$1.57M 10-K · filed 2025-03-24 |
| 2023-09-30 | -$182.00K 10-Q · filed 2023-11-08 | -$615.00K derived: sum of 2 quarters · filed 2023-11-08 | -$921.00K 10-Q · filed 2023-11-08 | -$1.64M derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-06-30 | -$433.00K 10-Q · filed 2023-08-09 | -$739.00K 10-Q · filed 2023-08-09 | -$1.46M derived: sum of 3 quarters · filed 2024-03-15 | -$2.71M derived: sum of 4 quarters · filed 2024-03-15 |
| 2023-03-31 | -$306.00K 10-Q · filed 2023-05-10 | -$1.02M derived: sum of 2 quarters · filed 2024-03-15 | -$2.27M derived: sum of 3 quarters · filed 2024-03-15 | -$3.02M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-12-31 | -$719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$1.97M derived: sum of 2 quarters · filed 2024-03-15 | -$2.72M derived: sum of 3 quarters · filed 2024-03-15 | -$4.28M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$1.25M 10-Q · filed 2023-11-08 | -$2.00M derived: sum of 2 quarters · filed 2023-11-08 | -$3.56M 10-Q · filed 2023-11-08 | -$4.28M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$747.00K 10-Q · filed 2023-08-09 | -$2.31M 10-Q · filed 2023-08-09 | -$3.03M derived: sum of 3 quarters · filed 2023-08-09 | -$3.83M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$1.56M 10-Q · filed 2023-05-10 | -$2.29M derived: sum of 2 quarters · filed 2023-05-10 | -$3.09M derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$1.53M derived: sum of 2 quarters · filed 2023-03-23 | -$2.78M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$802.00K 10-Q · filed 2022-11-15 | -$2.06M 10-Q · filed 2022-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |